Animalcare’s FY25 results follow the company’s mid-January trading update and also come in the context of the recommended cash offer announced earlier this month. As we commented in our note of 16 April 2026, we view the offer as a fairly straightforward bid at full value, but very unfortunately looks like an exit from AIM for one of the sector’s highest-quality companies and teams. We remind investors that the transaction is being done via a scheme of arrangement, with timing guided to 2Q-3Q th ....
